The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Petros Pharmaceuticals(NASDAQ:PTPI) 
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an approved PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializ...
Website: http://www.petrospharma.com
Founded: 2020
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Share this website to your friends
Petros Pharmaceuticals Days Payable Outstanding ttm (DPO)
Petros Pharmaceuticals Days Receivable Outstanding ttm (DSO)
Petros Pharmaceuticals Days Inventory Outstanding ttm (DIO)
Petros Pharmaceuticals Op Cashflow Per Share ttm
Petros Pharmaceuticals Free Cashflow Per Share ttm
Petros Pharmaceuticals Cash Per Share ttm
Petros Pharmaceuticals P/S ratio ttm
Petros Pharmaceuticals (GAAP) P/E ratio ttm
Petros Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.